Rie Ota1, Masako Kataoka1, Mami Iima1, Ayami Ohno Kishimoto2, Maya Honda3, Kanae Kawai Miyake1, Yosuke Yamada4, Yasuhide Takeuchi4, Masakazu Toi5, and Yuji Nakamoto1
1Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University graduate school of medicine, Kyoto, Japan, 2Department of Diagnostic Radiology, Kyoto Katsura Hospital, Kyoto, Japan, 3Department of Diagnostic Radiology, Kansai Electric Power Hospital, Osaka, Japan, 4Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan, 5Department of Breast Surgery, Kyoto University Hospital, Kyoto, Japan
Synopsis
This study aimed to evaluate the diagnostic
performance of non-contrast protocol combining high-resolution diffusion
weighted images (HR-DWI) with rs-EPI, T1WI and T2WI, using modified BI-RADS. In
total, 98 breast lesions (60 malignant and 38 benign lesions) were categorized
and compared to the pathological diagnosis. Area under the ROC curve (AUC)s of the
non-contrast protocol were 0.90 (95% confidence interval (95%CI) : 0.82-0.95) for both readers. When excluding cases in which ADC value could not be
measured, the AUC values were improved. Non-contrast protocol with modified
BI-RADS can be used to evaluate breast lesions.
Introduction:
High-resolution DWI (HR-DWI) using rs-EPI
(abbreviated as HR-DWI hereafter) demonstrated excellent agreement with DCE-MRI
in morphology and lesion extent [1, 2]. This
evidence implies the potential use of BI-RADS based descriptors for
non-contrast MRI.
However, HR-DWI alone may not be sufficient
to achieve reasonable diagnostic performance. Adding information from other
non-contrast sequences may be useful [3]. The
purpose of this study is to evaluate the diagnostic performance of non-contrast
protocol combining HR-DWI, T1WI and T2WI, using modified BI-RADS 2013-based
assessment (Modified BI-RADS). Materials & Methods:
Study
population
Study population consisted of 98 females (mean
age 56, range 20–87 years old) with 108 lesions (pathologically confirmed as 63
malignant and 45 benign lesions) who were scanned with MRI including HR-DWI from
April 2017 and September 2019. Lesions for which ADC values could not be measured were
excluded (n=10), leaving 98 lesions (60 malignant and 38 benign) for final
analysis.
MRI
protocol
A
3T MRI system (MAGNETOM Prisma: Siemens Healthcare, Erlangen, Germany) with a
dedicated 18-channel breast coil was used for image acquisition. Our routine
protocol for breast lesions included fat-suppressed (FS) T1-weighted images (T1WI),
T2-weighted images (T2WI), HR-DWI using rs-EPI. Apparent diffusion coefficient
(ADC) maps were automatically created from DWI at b = 0 and 850 s/mm2.
Image
analysis
Modified BI-RADS with decision tree
Based
on previous studies [4], a diagnostic decision
tree was constructed using imaging findings of T1WI/T2WI and HR-DWI (Figure 1) to
categorize the lesions into 5 categories. Category 4 lesions were subclassified
into three subcategories 4A, 4B and 4C depending on the likelihood of
malignancy.
Two
experienced readers, blinded to the final pathological diagnosis, independently
categorized the lesions according to modified BI-RADS with diagnostic decision
tree. One rank higher category (or subcategories) is allocated if the lesion
showed “Large size”, ”low ADC value” ,edema (high signal intensity on T2WI), and a few other associated
features suggesting malignancy listed in figure 1. The lesions were categorized
as category 2, 3, 4A, 4B, 4C and 5. If the lesion could not be recognized, the
lesion was classified as Category 1. Category 5 and 4C are grouped as malignant
and category 2, 3, 4A and 4B as benign, and these groups were compared with
pathological diagnosis.
ADC
measurement
Both
readers measured the values on ADC maps by placing a maximum of three regions
of interest (ROI) of 3mm on each lesion. ADC values were calculated only from
the lesions in which ROIs could be placed. In each ROI, the average ADC values
were calculated and the lowest of the average ADC values was used as the
representative ADC value in each lesion.
Statistical analysis
The
diagnostic performance of modified BI-RADS in discriminating benign and
malignant lesions was assessed using a receiver operating characteristic (ROC)
analysis. The ADCs of the
benign and malignant lesions were compared using a Mann-Whitney test.Results:
The
modified BI-RDAS categories of the two readers were in agreement for 60 lesions
(54.1%) with a kappa value of 0.65 (95% confidence interval (95%CI): 0.57–0.73),
suggesting substantial agreement.
A
statistically significant difference of the mean ADC value was observed between
the malignant and the benign lesions for both readers (p < 0.001). ROC
analysis showed an area under the ROC curve (AUC) of 0.90 (95% CI: 0.82-0.95)
for both readers (Figure 2). The sensitivity and specificity were 83.3% and 86.8%
for reader 1, 75.0% and 92.1% for reader 2, respectively.
Images of representative cases were shown in Case 1 (malignant lesion)
and 2 (benign lesion).Discussion & Conclusion:
Combining
DWI, T1/T2WI, and ADC values provides increased accuracy for differentiation
between benign and malignant lesions, comparable to the accuracy with DCE-MRI[5]. The strengths of the
current analysis can be the use of high-resolution DWI that enabled detailed
morphological evaluation of malignant lesions. Among associated features,
lesion size and ADC values were proved to be useful features. In addition,
edema on T2WI contributed to the diagnosis of malignancy. Another strength is
the use of decision tree that helped in summarizing these key findings to
predict the probability of malignancy, as well as clarifying diagnostic
process.
The
drawback of the current method is the exclusion of lesions with difficulty in
measuring ADC value or even difficulty in detection. In that sense, accurate
diagnoses for small and non-mass lesions are challenging with non-contrast
protocol. Further development of HR-DWI allowing the ADC measurement of these
challenging lesions is awaited.
In
conclusion, non-contrast protocol including HR-DWI, T1/T2WI with modified
BI-RADS and decision tree can be used to evaluate breast lesions with excellent
diagnostic performance.Acknowledgements
No acknowledgment was found.References
- Kishimoto, A.O., et al., The
comparison of high-resolution diffusion weighted imaging (DWI) with
high-resolution contrast-enhanced MRI in the evaluation of breast cancers.
Magn Reson Imaging, 2020. 71: p.
161-169.
- Kishimoto, A.O.,
et al., Evaluation of Malignant Breast
Lesions Using High-resolution Readout-segmented Diffusion-weighted Echo-planar
Imaging: Comparison with Pathology. Magn Reson Med Sci, 2021. 20(2): p. 204-215.
- Trimboli, R.M., et
al., Breast cancer detection using double
reading of unenhanced MRI including T1-weighted, T2-weighted STIR, and
diffusion-weighted imaging: a proof of concept study. AJR Am J Roentgenol,
2014. 203(3): p. 674-81.
- Lee, S.H., H.J.
Shin, and W.K. Moon, Diffusion-Weighted
Magnetic Resonance Imaging of the Breast: Standardization of Image Acquisition
and Interpretation. Korean J Radiol, 2021. 22(1): p. 9-22.
-
Kim, K.W., et al.,
Diagnostic Usefulness of Combination of
Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient
in Breast Lesions: Assessment of Histologic Grade. Acad Radiol, 2018. 25(5): p. 643-652.